Emory Clinic, Atlanta VA Medical Center
Atlanta, Georgia, 30322, United States
NCT Number: NCT03381235
The purpose of this study is to look in humans at the relationship between moderate or little exercise and their potential effects on the retina in patients with Retinitis Pigmentosa (RP).
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Atlanta, Georgia, 30322, United States
Human studies have shown that regular exercise may have positive effects on common degenerative diseases such as Alzheimer's disease. Exercise has also shown to improve conditions the eye such as macular degenerations, glaucoma, and cataracts. Mice with retinal degeneration which were exposed to exercise showed that it helped to slow the rate of degeneration. The purpose of this study is to look in humans at the relationship between moderate or little exercise and their potential effects on the retina in patients with Retinitis Pigmentosa (RP).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each exercise class will consist of 20 minutes of progressive, interval based Spin exercise 2 times a week for 6 months on stationary exercise cycles and will be led by a qualified instructor. The Duration of each session is lengthened based on the progression of the participant and the recommendation of the instructor by 1-2 minutes as needed to a maximum time of 60 minutes per session. Exercise intensity will begin at low levels (50% of maximal heart rate reserve (HRR) and increase by 5% every week (if deemed necessary by the instructor) to a maximum of 75% maximal HRR.
Time frame: Baseline, 3 and 6 months follow up.
Sertum levels of BDNF in patients before and exercise program will be measured by testing blood
Time frame: Baseline, 3 and 6 months follow up.
Optical Coherence Tomography Angiography (OCTA) will serve as a tool to study retina vasculature, including choroidal, superficial and deep retinal vascular filling status and permeability, before and after exercise.
Time frame: Baseline, 3 and 6 months follow up.
Change in retinal thickness will be evaluated using spectral-domain optical coherence tomography (SD-OCT) before and after exercise.
Time frame: Baseline, 3 and 6 months follow up.
Change in retinal RPE pigmentation will be evaluated using Optos wide-field fundus photography before and after exercise.
Time frame: Baseline, 3 and 6 months follow up.
Change in degrees of vascular attenuation will be evaluated using Optos wide-field fundus photography before and after exercise.
Time frame: Baseline, 3 and 6 months follow up.
Change in amount of autofluorescence will be evaluated using autofluorescent imaging before and after exercise.
Time frame: Baseline, 3 and 6 months follow up.
The final result of a GVF is a diagram "island of vision." The visual field is an island with a central peak and the altitude correlates with the visual sensitivity in a given location.
Time frame: Baseline, 3 and 6 months follow up.
NEI VFQ-25 measures the range of vision-related functioning experienced by persons. The 12 subscales in the NEI VFQ-25 are general vision, near vision, distance vision, driving, peripheral vision, color vision, ocular pain, general health, and vision-specific role difficulties, dependency, social function, and mental health. The subscale scores are calculated by summing the relevant items and transforming the raw scores into a 0 to 100 scale where higher scores indicate better functioning or well-being.
Emory University
Other
The Effects of Exercise on Progression of Disease and Quality of Life in Patients With Retinitis Pigmentosa - a Small Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04945772
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Beverly Hills, California, United States
View Trial DetailsNCT01024803
Blindness, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Dresden, Germany
View Trial DetailsNCT06162585
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Beverly Hills, California, United States
View Trial DetailsNCT04805658
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Oslo, Norway
View Trial Details